This might be partially due to the high agreement between amyloid-PET and tau-PET (80% in the present study), as compared to studies showing a moderate correlation between amyloid-PET and tau-PET in cognitively normal individuals [29]. The gene discussed is MAPT; the disease is amyloidosis.